A detailed history of Venture Visionary Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Venture Visionary Partners LLC holds 44,768 shares of ABBV stock, worth $8.06 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
44,768
Previous 45,044 0.61%
Holding current value
$8.06 Million
Previous $7.73 Million 14.43%
% of portfolio
0.39%
Previous 0.36%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$163.84 - $199.33 $45,219 - $55,015
-276 Reduced 0.61%
44,768 $8.84 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $106,340 - $124,182
687 Added 1.55%
45,044 $7.73 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $86,302 - $98,334
-540 Reduced 1.2%
44,357 $8.08 Million
Q4 2023

Feb 15, 2024

BUY
$137.6 - $154.97 $70,864 - $79,809
515 Added 1.16%
44,897 $6.96 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $16,512 - $18,596
-120 Reduced 0.27%
44,382 $6.88 Million
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $63,989 - $74,077
-479 Reduced 1.06%
44,502 $6.63 Million
Q2 2023

Jul 14, 2023

BUY
$132.51 - $164.9 $130,787 - $162,756
987 Added 2.24%
44,981 $6.06 Million
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $133,619 - $153,882
924 Added 2.15%
43,994 $7.01 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $102,072 - $122,412
-738 Reduced 1.68%
43,070 $6.96 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $183,330 - $210,268
1,366 Added 3.22%
43,808 $5.88 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $111,334 - $141,542
809 Added 1.94%
42,442 $6.5 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $3.33 Million - $4.13 Million
-25,232 Reduced 37.74%
41,633 $6.75 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $383,095 - $484,726
3,566 Added 5.63%
66,865 $9.09 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $431,345 - $489,642
4,054 Added 6.84%
63,299 $6.85 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $366,762 - $408,594
3,486 Added 6.25%
59,245 $6.68 Million
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $2.23 Million - $2.46 Million
21,814 Added 64.26%
55,759 $6.03 Million
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $1.8 Million - $2.43 Million
22,382 Added 193.57%
33,945 $3.64 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $162,198 - $190,367
1,888 Added 19.51%
11,563 $1.05 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $186,726 - $249,868
2,545 Added 35.69%
9,675 $949,000
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $216,139 - $327,694
3,351 Added 88.67%
7,130 $543,000
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $272,579 - $341,054
3,779 New
3,779 $334,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Venture Visionary Partners LLC Portfolio

Follow Venture Visionary Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.